Recall Register

Device recall: Lactate Reagent (LACT 2 x 50), Catalog No. A95550 Intended for the quantitative determination of Lactate concentration…

Class II FDA enforcement event 76962. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Beckman Coulter has identified the following drugs as potential sources of interference: Metamizole (Dipyrone), Sulfasalazine, and Sulfapyridine and may result in false low results.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Beckman Coulter Inc. started this device recall on 3 Apr 2017. The firm address in the FDA record is in Brea, CA. FDA put the recall in Class II. FDA event 76962 has 7 product records. The first FDA enforcement report date is 24 May 2017. The record gives the status Terminated, with the termination date 31 May 2018.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide Distribution -- Australia, Bangladesh, Belgium, Brunei, Bulgaria, Canada, China, Colombia, Czech Republic, Egypt, Eritrea, Finland, France, Germany, Ghana, Greece, Guatemala, Hong Kong,…

Recalling firm

Beckman Coulter Inc., Brea, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

7 product records in the event.

FDA event 76962: product records
Recall numberProductQuantityClassStatusReport date
Z-2078-2017Lactate Reagent (LACT 2 x 50), Catalog No. A95550 Intended for the quantitative determination of Lactate concentration in human plasma and cerebrospinal fluid (CSF).92,837 units total (71,271 units in US)Class IITerminated24 May 2017
Z-2079-2017Uric Acid Reagent (URIC 2 x 300), Catalog No. 442785. Intended for the quantitative determination of uric acid concentration in human serum, plasma or urine.100,286 units total (20,732 units in US)Class IITerminated24 May 2017
Z-2080-2017Enzymatic Creatinine Reagent (CR-E 2 x 200), Catalog No. A60298. Intended for the quantitative determination of creatinine (CR-E) concentration in human serum, plasma or urine.12,665 units total (1,399 units in US)Class IITerminated24 May 2017
Z-2081-2017Cholesterol Reagent(CHOL 2 x 300), Catalog No. 467825 Intended for quantitative determination of cholesterol concentration in human serum or plasma.128,718 units total (47,858 units in US)Class IITerminated24 May 2017
Z-2082-2017HDL Cholesterol Reagent (HDL 2 x 200), Catalog No. A15625. Intended for quantitative determination of HDL cholesterol in the high density lipoprotein fraction of human serum or plasma.91,996 units total (51,027 units in US)Class IITerminated24 May 2017
Z-2083-2017Triglycerides Reagent (TG 2 x 300), Catalog No. 445850. Intended for quantitative determination of triglycerides concentration in human serum or plasma.124,068 units total (47,920 units in US)Class IITerminated24 May 2017
Z-2084-2017Salicylate Reagent (SALY 2 x 45), Catalog No. 378194. Intended for quantitative determination of salicylate concentration in human serum or plasma.50,645 units total (43,816 units in US)Class IITerminated24 May 2017

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2017
1,091
Share of these events in Class II
93%
Product records in this event
7Median of the firm: 1
Events of the firm on the register
216

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 76962. https://recallregister.com/fda/ii/76962/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide Distribution -- Australia, Bangladesh, Belgium, Brunei, Bulgaria, Canada, China, Colombia, Czech Republic, Egypt, Eritrea, Finland, France, Germany, Ghana, Greece, Guatemala, Hong Kong,…
What quantity of product is in FDA event 76962?
The event has 7 product records. The first record gives this quantity: 92,837 units total (71,271 units in US)
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2017 have the same class?
93% of the 1,091 device events that started in 2017 are in Class II.